# Trade Mark Journal No.2025/030 25 July 2025

## WO0000001862941 (5)

Office of origin: United States of America

Date of International Registration:6 June 2025
Date of designation in the UK: 6 June 2025

International priority date claimed: 18 December 2024 (Trinidad and Tobago) (61374)

Class 5
  Pharmaceuticals.

Denali Therapeutics Inc.

Representative: Chelseaa Larsen Sheppard Mullin Richter & Hampton, LLP, 1540 El Camino Real, Suite 120, Menlo Park CA 94025, UNITED STATES OF AMERICA